Groupe Hospitalier Pitié-Salpêtrière

Paris 75651 Cedex 13

1 studies enrolling now · 12 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Ankylosing Spondyloarthritis, Chronic Hepatitis C, Frontotemporal Dementia, Liver Fibrosis Due to NASH, Neurodegenerative Diseases, Non-Hodgkin Lymphoma, Obstructive Hypertrophic Cardiomyopathy, Pancreatic Cancer Non-resectable, Psoriatic Arthritis, Stress Urinary Incontinence (SUI), T-Cell Lymphoma

Studies at this site

A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS) — Recruiting now
Continuation Study for Latozinemab — Stopped early
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) — Stopped early
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer — Completed
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy — Completed
Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia — Completed
Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) — Stopped early
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed